Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study-Reference-Cited by-同舟云学术

Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study

Published:2015-10-16 Issue:12 Volume:4 Page:1836-1843
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Nakano Masahito¹,Tanaka Masatoshi²,Kuromatsu Ryoko¹,Nagamatsu Hiroaki³,Tajiri Nobuyoshi¹,Satani Manabu¹,Niizeki Takashi¹,Aino Hajime¹,Okamura Shusuke¹,Iwamoto Hideki¹,Shimose Shigeo¹,Shirono Tomotake¹,Koga Hironori¹,Torimura Takuji¹,

Affiliation:

1. Division of Gastroenterology Department of Medicine Kurume University School of Medicine Kurume Fukuoka Japan

2. Yokokura Hospital Miyama Fukuoka Japan

3. Yame General Hospital Yame Fukuoka Japan

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.548

Reference31 articles.

1. Rising Incidence of Hepatocellular Carcinoma in the United States

2. Early hepatocellular carcinoma as an entity with a high rate of surgical cure

3. Randomized controlled trial of screening for hepatocellular carcinoma

4. Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma

5. Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated virtual screening and MD simulation approaches toward discovering potential inhibitors for targeting BRPF1 bromodomain in hepatocellular carcinoma;Journal of Molecular Graphics and Modelling;2024-01

2. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity;Clinical and Molecular Hepatology;2023-07-01

3. Production of a biosimilar version of aflibercept to improve VEGF blocker cytotoxicity on endothelial cells;Growth Factors;2023-06-28

4. Sorafenib as first-line treatment for patients with primary hepatocellular carcinoma: an outcome evaluation;Journal of International Medical Research;2023-06

5. Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma;Cancers;2023-02-28